Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 245 | 445 | 417 | 446 | 756 |
| Cost of Goods | N/A | N/A | N/A | N/A | 954 |
| Gross Profit | 245 | 445 | 417 | 446 | -198 |
| Operating Expenses | 7,014 | 9,158 | 17,571 | 17,887 | 20,065 |
| Operating Income | -6,770 | -8,713 | -17,154 | -17,441 | -19,309 |
| Interest Expense | 3 | 6,340 | 550 | 0 | 0 |
| Other Income | 2,037 | -1,106 | 102 | 556 | 716 |
| Pre-tax Income | -4,736 | -16,158 | -17,602 | -16,885 | -18,593 |
| Net Income Continuous | -4,736 | -16,158 | -17,602 | -16,885 | -18,593 |
| Net Income Discontinuous | N/A | 4,478 | -6,996 | -8,436 | N/A |
| Net Income | $-4,736 | $-11,681 | $-24,598 | $-25,322 | $-18,593 |
| EPS Basic Total Ops | -1.20 | -4.80 | -11.00 | -12.80 | -11.80 |
| EPS Basic Continuous Ops | -1.28 | -6.60 | -7.80 | -8.60 | -11.88 |
| EPS Basic Discontinuous Ops | N/A | 1.80 | -3.20 | -4.20 | N/A |
| EPS Diluted Total Ops | -1.20 | -4.80 | -11.00 | -12.80 | -11.80 |
| EPS Diluted Continuous Ops | -1.28 | -6.60 | -7.80 | -8.60 | -11.88 |
| EPS Diluted Discontinuous Ops | N/A | 1.80 | -3.20 | -4.20 | N/A |
| EBITDA(a) | $-6,589 | $-2,490 | $-15,062 | $-16,269 | $-18,388 |